221 related articles for article (PubMed ID: 29529529)
1. The putative interplay between DJ-1/NRF2 and Dimethyl Fumarate: A potentially important pharmacological target.
Vavougios G; Zarogiannis SG; Doskas T
Mult Scler Relat Disord; 2018 Apr; 21():88-91. PubMed ID: 29529529
[TBL] [Abstract][Full Text] [Related]
2. Dimethyl Fumarate Controls the NRF2/DJ-1 Axis in Cancer Cells: Therapeutic Applications.
Saidu NE; Noé G; Cerles O; Cabel L; Kavian-Tessler N; Chouzenoux S; Bahuaud M; Chéreau C; Nicco C; Leroy K; Borghese B; Goldwasser F; Batteux F; Alexandre J
Mol Cancer Ther; 2017 Mar; 16(3):529-539. PubMed ID: 28069874
[TBL] [Abstract][Full Text] [Related]
3. Dimethyl Fumarate and Monomethyl Fumarate Promote Post-Ischemic Recovery in Mice.
Yao Y; Miao W; Liu Z; Han W; Shi K; Shen Y; Li H; Liu Q; Fu Y; Huang D; Shi FD
Transl Stroke Res; 2016 Dec; 7(6):535-547. PubMed ID: 27614618
[TBL] [Abstract][Full Text] [Related]
4. Dimethyl fumarate and monoethyl fumarate exhibit differential effects on KEAP1, NRF2 activation, and glutathione depletion in vitro.
Brennan MS; Matos MF; Li B; Hronowski X; Gao B; Juhasz P; Rhodes KJ; Scannevin RH
PLoS One; 2015; 10(3):e0120254. PubMed ID: 25793262
[TBL] [Abstract][Full Text] [Related]
5. Evidence of activation of the Nrf2 pathway in multiple sclerosis patients treated with delayed-release dimethyl fumarate in the Phase 3 DEFINE and CONFIRM studies.
Gopal S; Mikulskis A; Gold R; Fox RJ; Dawson KT; Amaravadi L
Mult Scler; 2017 Dec; 23(14):1875-1883. PubMed ID: 28156185
[TBL] [Abstract][Full Text] [Related]
6. Dimethyl fumarate and curcumin attenuate hepatic ischemia/reperfusion injury via Nrf2/HO-1 activation and anti-inflammatory properties.
Ibrahim SG; El-Emam SZ; Mohamed EA; Abd Ellah MF
Int Immunopharmacol; 2020 Mar; 80():106131. PubMed ID: 31981960
[TBL] [Abstract][Full Text] [Related]
7. Insight into the mechanism of action of dimethyl fumarate in multiple sclerosis.
Yadav SK; Soin D; Ito K; Dhib-Jalbut S
J Mol Med (Berl); 2019 Apr; 97(4):463-472. PubMed ID: 30820593
[TBL] [Abstract][Full Text] [Related]
8. Control of Oxidative Stress and Inflammation in Sickle Cell Disease with the Nrf2 Activator Dimethyl Fumarate.
Belcher JD; Chen C; Nguyen J; Zhang P; Abdulla F; Nguyen P; Killeen T; Xu P; O'Sullivan G; Nath KA; Vercellotti GM
Antioxid Redox Signal; 2017 May; 26(14):748-762. PubMed ID: 26914345
[TBL] [Abstract][Full Text] [Related]
9. Dimethyl Fumarate Protects Neural Stem/Progenitor Cells and Neurons from Oxidative Damage through Nrf2-ERK1/2 MAPK Pathway.
Wang Q; Chuikov S; Taitano S; Wu Q; Rastogi A; Tuck SJ; Corey JM; Lundy SK; Mao-Draayer Y
Int J Mol Sci; 2015 Jun; 16(6):13885-907. PubMed ID: 26090715
[TBL] [Abstract][Full Text] [Related]
10. Inhibiting inflammation and modulating oxidative stress in oxalate-induced nephrolithiasis with the Nrf2 activator dimethyl fumarate.
Zhu J; Wang Q; Li C; Lu Y; Hu H; Qin B; Xun Y; Zhu Y; Wu Y; Zhang J; Wang S
Free Radic Biol Med; 2019 Apr; 134():9-22. PubMed ID: 30599261
[TBL] [Abstract][Full Text] [Related]
11. Dimethyl fumarate suppresses Theiler's murine encephalomyelitis virus-induced demyelinating disease by modifying the Nrf2-Keap1 pathway.
Kobayashi K; Tomiki H; Inaba Y; Ichikawa M; Kim BS; Koh CS
Int Immunol; 2015 Jul; 27(7):333-44. PubMed ID: 25721871
[TBL] [Abstract][Full Text] [Related]
12. DJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2.
Clements CM; McNally RS; Conti BJ; Mak TW; Ting JP
Proc Natl Acad Sci U S A; 2006 Oct; 103(41):15091-6. PubMed ID: 17015834
[TBL] [Abstract][Full Text] [Related]
13. The Challenge of Dimethyl Fumarate Repurposing in Eye Pathologies.
Manai F; Govoni S; Amadio M
Cells; 2022 Dec; 11(24):. PubMed ID: 36552824
[TBL] [Abstract][Full Text] [Related]
14. A comparison study between dimethyl itaconate and dimethyl fumarate in electrophilicity, Nrf2 activation, and anti-inflammation
Zhang Y; Zhou YJ; Tang JS; Lan JQ; Kang YY; Wu L; Peng Y
J Asian Nat Prod Res; 2022 Jun; 24(6):577-588. PubMed ID: 34292106
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic efficacy of dimethyl fumarate in relapsing-remitting multiple sclerosis associates with ROS pathway in monocytes.
Carlström KE; Ewing E; Granqvist M; Gyllenberg A; Aeinehband S; Enoksson SL; Checa A; Badam TVS; Huang J; Gomez-Cabrero D; Gustafsson M; Al Nimer F; Wheelock CE; Kockum I; Olsson T; Jagodic M; Piehl F
Nat Commun; 2019 Jul; 10(1):3081. PubMed ID: 31300673
[TBL] [Abstract][Full Text] [Related]
16. Elevated levels of 8-OHdG and PARK7/DJ-1 in peri-implantitis mucosa.
Kasnak G; Firatli E; Könönen E; Olgac V; Zeidán-Chuliá F; Gursoy UK
Clin Implant Dent Relat Res; 2018 Aug; 20(4):574-582. PubMed ID: 29787640
[TBL] [Abstract][Full Text] [Related]
17. Electrophiles Against (Skin) Diseases: More Than Nrf2.
Hennig P; Fenini G; Di Filippo M; Beer HD
Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32053878
[TBL] [Abstract][Full Text] [Related]
18. Dimethyl fumarate confers neuroprotection by casein kinase 2 phosphorylation of Nrf2 in murine intracerebral hemorrhage.
Iniaghe LO; Krafft PR; Klebe DW; Omogbai EKI; Zhang JH; Tang J
Neurobiol Dis; 2015 Oct; 82():349-358. PubMed ID: 26176793
[TBL] [Abstract][Full Text] [Related]
19. Dimethyl fumarate mediates Nrf2-dependent mitochondrial biogenesis in mice and humans.
Hayashi G; Jasoliya M; Sahdeo S; Saccà F; Pane C; Filla A; Marsili A; Puorro G; Lanzillo R; Brescia Morra V; Cortopassi G
Hum Mol Genet; 2017 Aug; 26(15):2864-2873. PubMed ID: 28460056
[TBL] [Abstract][Full Text] [Related]
20. Pharmacodynamics of Dimethyl Fumarate Are Tissue Specific and Involve NRF2-Dependent and -Independent Mechanisms.
Brennan MS; Patel H; Allaire N; Thai A; Cullen P; Ryan S; Lukashev M; Bista P; Huang R; Rhodes KJ; Scannevin RH
Antioxid Redox Signal; 2016 Jun; 24(18):1058-71. PubMed ID: 26980071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
